{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} CE Credit - Infusion Topics: Transfusion Antibodies; SPC Phlebitis Factors; Small Volume Infusions; Single vs Double Lumen PICCs; Parenteral Nutrition; SPC Phlebitis Treatment
Activity Steps
Description
By participating in this activity you will earn CE Credit.This issue contains the following articles:- Antibody Formation in Transfusion Therapy
- Factors Contributing to Phlebitis Among Adult Patients Admitted in the Medical-Surgical Units of a Central Hospital in Harare, Zimbabwe
- Optimizing Drug Delivery of Small-Volume Infusions
- Selection of Single- Versus Double-Lumen Peripherally Inserted Central Catheters and the Influence on Alteplase Use
- Does a Dedicated Lumen for Parenteral Nutrition Administration Reduce the Risk of Catheter-Related Bloodstream Infections? A Systematic Literature Review
- A Randomized Controlled Study to Evaluate the Effectiveness of 2 Treatment Methods in Reducing Incidence of Short Peripheral Catheter-Related Phlebitis
Purpose of Activity
To provide information on current issues affecting infusion nursing practice.Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize the role of antibody formation in the development of complications related to blood product transfusions.
- Outline the results of a literature review and a study on risk factors for phlebitis related to the use of short peripheral catheters (SPCs).
- Compare the pinch and backflush techniques for administering residual medication from an intravenous piggyback (IVPB) infusion set after administering small-volume infusions.
- Select risk factors for thrombosis in peripherally inserted central catheters (PICCs).
- Evaluate the findings from a literature review on rates of catheter-related bloodstream infections (CR-BSIs) in patients with central vascular access devices (CVADs) who received parenteral nutrition (PN).
- Specify issues related to phlebitis and results of a study aimed at reducing the incidence of phlebitis from SPCs.
Disclosures
Author Maria Isabel Castillo is a research fellow with the Alliance for Vascular Access Teaching and Research Group (AVATAR) at Menzies Health Institute Queensland; Samantha Keogh is the principal director at AVATAR; Claire M Rickard is a director at AVATAR. AVATAR receives occa- sional consultancy payments from the following companies: 3M, Angiodynamics, Baxter, B Braun, Becton Dickinson, Carefusion, Centurion, Cook Medical, Entrotech, Hospira, ResQ, Smith Medical, Teleflex, and Vygon. The educational activity has been reviewed and all potential or actual con- flicts have been resolved. All authors and planners have disclosed no other potential conflicts of interest, financial or otherwise, related to this publication.
Credits:
- ANCC 4.5 CH
- DC - BON 4.5 CH
- KY-BON 4.5 CH
- GA - BON 4.5 CH